Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Molnumize 200mg Capsule

Prescription Icon
Prescription Required

Marketer

Torrent Pharmaceuticals Ltd

Salt Composition

Molnupiravir (200mg)

Overview Molnumize 200mg Capsule

For adults with mild to moderate COVID-19, Molnumize 200mg capsules offer the first oral antiviral treatment. This medication curbs viral replication, lessening the viral burden and disease intensity. Indian drug regulators granted emergency authorization on December 28, 2021. Molnumize 200mg is solely for individuals with mild to moderate COVID-19 symptoms at high risk of severe illness (e.g., obesity, age over 60, diabetes, heart conditions). It's unsuitable for those needing immediate hospitalization. The U.S. FDA and UK regulatory bodies have also granted emergency approval. The oral course should not exceed five consecutive days; complete the full five-day regimen regardless of symptom improvement. Potential side effects include dizziness, headache, diarrhea, and nausea. Report any side effects to your physician for management or preventative strategies. Always disclose pre-existing conditions and all other medications to your doctor before starting Molnumize 200mg. Its use is not advised during pregnancy; pregnant or breastfeeding individuals should seek medical counsel before use.

Primary Ingredients of Molnumize 200mg Capsule

No text provided. Please provide the text you would like me to rephrase.

Uses of Molnumize 200mg Capsule

Managing mild to moderate cases of COVID-19

Major Benefits of Molnumize 200mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Molnumize 200mg Capsules can be administered with or without food, although consistent timing is recommended.

Common Side effects of Molnumize 200mg Capsule:

  • Nausea
  • Dizziness
  • Diarrhea

How to use Molnumize 200mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Molnumize 200mg Capsules can be administered with or without food, though consistent timing is recommended.

How Molnumize 200mg Capsule works:

The antiviral medication Molnumize 200mg Capsules acts by suppressing SARS-CoV-2 replication. This mechanism reduces viral production, thereby lowering the overall viral burden within the patient.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Molnumize 200mg Capsules may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Molnumize 200mg Capsules during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Lactation and Molnumize 200mg capsules are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability while using Molnumize 200mg Capsules is undetermined. Refrain from driving if any concentration or reaction-impairing symptoms arise.

KidneyKidneySAFE IF PRESCRIBED

Molnumize 200mg capsules can be administered to patients with renal impairment without requiring dosage modification.

LiverLiverSAFE IF PRESCRIBED

Molnumize 200mg capsules are considered safe for use in individuals with hepatic impairment. No alteration of the Molnumize 200mg capsule dosage is necessary.

What if you forget to take Molnumize 200mg Capsule :

Should you forget to take a Molnumize 200mg capsule, seek medical advice.

Facts to Know About Molnumize 200mg Capsule

LabelValue
Chemical Category Cytosine-containing nucleotides
Developing Habits No.
Treatment Category Antimicrobials
Action Class Non-HIV antiviral medications

FAQs on Molnumize 200mg Capsule

Molnumize 200mg Capsules are not approved for use in individuals under 18 due to potential interference with bone and cartilage development.
Molnumize 200mg Capsules offer improved patient adherence compared to some other COVID-19 treatments. Its oral administration simplifies usage, eliminating the need for healthcare professional involvement, unlike some other medications. Patients take it by mouth as directed by their physician.
Molnumize 200mg Capsules carry significant risks, potentially causing birth defects in pregnant women and severe bone and cartilage damage, leading to serious muscle problems. Use is strictly limited to cases where a doctor prescribes it; self-medication is strongly discouraged.
No, Molnumize 200mg Capsules and vaccination are not comparable. Vaccination prevents COVID-19, while Molnumize treats the infection only if diagnosed early.
Individuals at heightened risk of severe COVID-19 are those over 60, obese, or with pre-existing conditions such as high blood pressure, diabetes, asthma, lung or kidney disease (including dialysis patients), liver disease, or weakened immunity (e.g., cancer patients).
Molnumize 200mg Capsules are not for COVID-19 prevention or treatment in hospitalized patients. Ongoing clinical trials show no benefit for those severely ill with COVID-19.
Molnumize 200mg Capsule
596
MRP 690
13% off